INHIBITOR MSA367; N,N-[2,5-O-DIBENZYL-GLUCARYL]-DI-[VALINYL-AMINOMETHANYL-PYRIDINE]; 1ec3; MS3; symmetric/asymmetric inhibitor 9; BDBM12222; DB03803; Q27463508; (2R,3R,4R,5R)-2,5-bis(benzyloxy)-3,4-dihydroxy-N,N''-bis[(1S)-2-methyl-1-[(pyridin-2-ylmethyl)carbamoyl]propyl]hexanediamide; (2R,3R,4R,5R)-2,5-dibenzyloxy-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-(2-pyridylmethylcarbamoyl)propyl]hexanediamide; 2,5-Bis-benzyloxy-3,4-dihydroxy-hexanedioic acid, bis-({2-methyl-1-[(pyridin-2-ylmethyl)-carbamoyl]-propyl}-amide)